Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study
Purpose: To evaluate and compare the efficacy and safety of interferon alpha-2a (IFN-α2a) and cyclosporine-A (CsA) in patients with refractory Behçet’s uveitis (BU).Methods: In this 12-month randomized, controlled, prospective trial, 26 participants (44 eyes) completed the study. Patients were rando...
Main Authors: | Yujing Qian, Yi Qu, Fei Gao, Minghang Pei, Anyi Liang, Junyan Xiao, Chan Zhao, Meifen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.699903/full |
Similar Items
-
Genetic Association of Interleukin 33/ST2 Polymorphisms With Behcet’s Uveitis
by: Minghang Pei, et al.
Published: (2021-03-01) -
Interferon-α2a treatment for refractory Behçet's disease
by: Yung Jen Lai, et al.
Published: (2018-01-01) -
Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
by: Ji Hwan Lee, et al.
Published: (2018-02-01) -
Profiling tear proteomes of patients with unilateral relapsed Behcet’s disease-associated uveitis using data-independent acquisition proteomics
by: Anyi Liang, et al.
Published: (2020-06-01) -
Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
by: Katsuyama A, et al.
Published: (2019-03-01)